Priligy maker Menarini puts rugby players on cinema screens in premature-ejaculation awareness push

Italy-based Menarini, which markets the premature ejaculation treatment Priligy (dapoxetine), has launched an awareness campaign in the U.K. featuring tough-guy rugby players. "Firing Too Quickly" will include nationwide advertising in cinemas, along with information and support on the campaign website. Report

Suggested Articles

Consensus pegs cabotegravir peak sales at £750 million ($945 million), indicating it can grab about one-third of the current PrEP market.

Their merger isn't official yet, but a new logo is ready to go: Mylan and Pfizer's Upjohn unit unveiled new branding for their Viatris combo Thursday.

AbbVie's Allergan received a positive early ruling in its long-running trade secrets dispute with Evolus over a competitor to blockbuster Botox.